Vor Ort
Merkzettel Warenkorb
Produktbild: Anticancer Drug Development Guide
- 11%

Anticancer Drug Development Guide Preclinical Screening, Clinical Trials, and Approval

Aus der Reihe Cancer Drug Discovery and Development
11% sparen

96,99 € UVP 109,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.06.2013

Herausgeber

Beverly A. Teicher

Verlag

Humana Press

Seitenzahl

311

Maße (L/B/H)

25,4/17,8/1,8 cm

Gewicht

576 g

Auflage

Softcover reprint of the original 1st ed. 1997

Sprache

Englisch

ISBN

978-1-4615-8154-3

Beschreibung

Rezension

"Authoritative and up-to-date...takes oncologists, pharmacologists, medicinal chemists and other cancer researchers on an encyclopedic tour of the cancer drug development and approval process, moving from the design and execution of high throughput screens, to preclinical testing under FDA requirements, to early clinical trials, and on to final FDA approval." - Tumori

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.06.2013

Herausgeber

Beverly A. Teicher

Verlag

Humana Press

Seitenzahl

311

Maße (L/B/H)

25,4/17,8/1,8 cm

Gewicht

576 g

Auflage

Softcover reprint of the original 1st ed. 1997

Sprache

Englisch

ISBN

978-1-4615-8154-3

Herstelleradresse

Humana Press Inc.
Riverview Drive 999
07512 Totowa
US
Email: sdc-bookservice@springer.com
Telephone: +49 6221 3454301
Fax: +49 6221 3454229

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Anticancer Drug Development Guide
  • Part I. In Vitro Methods. High-Volume Screening, Michel Pagé. The NCI In Vitro Anticancer Drug Discovery Screen: Concept, Implementation, and Operation, 1985-1995, Michael R. Boyd. Human Tumor Screening, Axel-R. Hanauske, Susan G. Hilsenbeck, and Daniel D. Von Hoff. Part II. In Vivo Methods. Murine L1210 and P388 Leukemias, William R. Waud. In Vivo Methods for Screening and Preclinical Testing: Use of Rodent Solid Tumors for Drug Discovery, Thomas Corbett, Fred Valeriote, Patricia LoRusso, Lisa Polin, Chiab Panchapor, Susan Pugh, Kathryn White, Juiwanna Knight, Lisa Demchik, Julie Jones, Lynne Jones, and Loretta Lisow. Human Tumor Xenograft Models in NCI Drug Development, Jaqueline Plowman, Donald J. Dykes, Melinda Hollingshead, Linda Simpson-Herren, and Michael C. Alley. Fertile Seed and Rich Soil: The Development of Clinically Relevant Models of Human Cancer by Surgical Orthotopic Implantation of Intact Tissue, Robert M. Hoffman. Preclinical Models for High-Dose Therapy, Beverly A. Teicher. Models for Minimal Residual Tumor, Beverly A. Teicher. Spontaneously Occurring Tumors in Companion Animals as Models for Drug Development, David M. Vail and E. Gregory MacEwen. Part III. Clinical Testing. Working with the National Cancer Institute, Edward A. Sausville. Phase I Trial Design and Methodology, Deborah L. Toppmeyer. Phase II Clinical Trials in Oncology, Christine Khater, Paul Laub, James M. Gallo, André Rogatko, and Peter J. O'Dwyer. Drug Development in Europe, Thomas Anthony Connors and Herbert M. Pinedo. The Phase III Cancer Clinical Trial, Emil Frei III. FDA Role in Cancer Drug Development and Requirements for Approval, Robert L. Justice. Index.